1. Home
  2. Alphabetical Drug Index - P
  3. Proprietary Name: Plerixafor

Plerixafor

List of products in the National Drug Code with proprietary name plerixafor. Plerixafor is used by patients with certain types of cancer (non-Hodgkin's lymphoma-NHL, multiple myeloma-MM) to prepare them for stem cell transplant. Stem cells, which are found mainly in the bone marrow, turn into red blood cells, white blood cells, and platelets. Plerixafor is used to help stem cells move from the bone marrow to the bloodstream so that the cells can be collected and stored. The stem cells are then infused back into the patient after chemotherapy or radiation.

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Labeler Name Product Type
25021-416Plerixafor PlerixaforInjection, SolutionSubcutaneousSagent PharmaceuticalsHuman Prescription Drug
31722-373Plerixafor PlerixaforInjection, SolutionSubcutaneousCamber Pharmaceuticals, Inc.Human Prescription Drug
43598-308Plerixafor PlerixaforSolutionSubcutaneousDr. Reddy's Laboratories IncHuman Prescription Drug
55150-356Plerixafor PlerixaforSolutionSubcutaneousEugia Us LlcHuman Prescription Drug
65219-284Plerixafor PlerixaforInjection, SolutionSubcutaneousFresenius Kabi Usa, LlcHuman Prescription Drug
68083-155Plerixafor PlerixaforInjection, SolutionSubcutaneousGland Pharma LimitedHuman Prescription Drug
70121-1694Plerixafor PlerixaforInjection, SolutionSubcutaneousAmneal Pharmaceuticals LlcHuman Prescription Drug
70710-1208Plerixafor PlerixaforInjectionSubcutaneousZydus Pharmaceuticals Usa Inc.Human Prescription Drug
70771-1776Plerixafor PlerixaforInjectionSubcutaneousZydus Lifesciences LimitedHuman Prescription Drug
71288-155Plerixafor PlerixaforSolutionSubcutaneousMeitheal Pharmaceuticals Inc.Human Prescription Drug
72162-2642Plerixafor PlerixaforInjection, SolutionSubcutaneousBryant Ranch PrepackHuman Prescription Drug
72205-249Plerixafor PlerixaforInjection, SolutionSubcutaneousNovadoz Pharmaceuticals LlcHuman Prescription Drug
0480-4320Plerixafor Teva Pharmaceuticals, Inc.